Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: August 3, 2000
Last updated: July 27, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2004
  Primary Completion Date: February 2003 (Final data collection date for primary outcome measure)